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Background
Late-onset Alzheimer’s disease (LOAD) is a complex
disorder with a significant genetic component (heritabil-
ity ~ 0.8). It is distressingly common: in the United
States, approximately 13% of individuals over the age of
65 and 43% of individuals over the age of 85 are esti-
mated to have AD [2011 Alzheimer’s Disease Facts and
Figures, Alzheimer’s Association]. Although specific
mutations have been linked to familial forms of AD,
mutations in AD candidate genes among LOAD cases
are rare. For this reason there is currently great interest
in identifying common genetic variants that contribute
to this disorder. The goal of the current study is to
quantify allele-specific differences in the expression of
mRNAs encoding candidate LOAD susceptibility genes
in human brain and elucidate the genetic basis for this
differential expression. Haplotypes or combinations of
genotypes that correlate with mRNA should be useful as
markers in future genetic association studies aimed at
identifying genes that contribute to AD risk and
protection.
Methods
We examined the expression of mRNAs for candidate
LOAD genes in human brain using a novel PCR/sec-
ond-generation DNA sequencing-based assay for quanti-
fying allelic expression imbalance (AEI) of mRNA
expression. Population distributions of log2AEI ratios
were analyzed using a custom mathematical model that
yields information concerning the number, locations,
and relative contributions of cis-acting regulatory var-
iants that influence mRNA expression.
Results
We determined population distributions of log2AEI
ratios for 24 candidate LOAD genes, including ABCA1,
ADAM17, AGER, BACE1, BACE2, BDNF, CALHM1,
CH25H, CLU, GAB2, GSK3B, LRP1, MAPT, NTRK2,
P25, PICALM, PION, PSEN1, PSEN2, SORCS1, SORL,
TNFRSF1, TNFRS21 AND TNK1. Among these, 22
genes showed frequent (> 0.1) and significant (> 1.2-
fold) allele-specific differences in mRNA expression.
Mathematical modeling predicted that individual genes
are regulated by one to three cis-acting elements. We
are currently working on identifying haplotypes or com-
binations of genotypes that predict high- or low-levels
of mRNA expression for use as markers in genetic asso-
ciation studies. Combining this information with knowl-
edge of the functions of genes within biological
pathways implicated in LOAD, will allow predictions of
the contributions of specific haplotypes to the disorder.
For example, high-expression haplotypes for genes
encoding proteins that increase the production of toxic
A-beta, are predicted to increase risk of LOAD, while
high-expression haplotypes for genes encoding proteins
that increase the degradation or clearance of A-beta, are
predicted in decrease the risk of LOAD. In addition to
simply examining differences in haplotypes frequencies
between case and control populations, the ability to
classify haplotypes as risk-conferring or protective allows
the calculation of polygenic risk scores to each indivi-
dual in the case and control groups. If our classification
scheme has validity, we would expect the mean poly-
genic risk scores for cases to be higher than controls.
Association studies to test these ideas are currently in
progress.
Conclusions
We have successfully used a novel high-throughput
assay for quantifying common variation in mRNA
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and are employing a custom mathematical model to
infer the number, contribution and locations of cis-act-
ing regulatory variants that influence mRNA expression.
We plan to uses data within a polygenic model for
LOAD risk to test the hypothesis that common regula-
tory variants contribute to the etiology of this disorder.
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